Although a replacement of PKM2 with PKLR was observed as the disease progresses to NASH via immunohistochemistry and Western blotting (Figure 4), the actual mechanism of regulation of PKLR and PKM2 expression levels was presumed to be different. The gene discussed is PKM; the disease is metabolic dysfunction-associated steatohepatitis.